XNK Therapeutics (formerly CellProtect Nordic Pharmaceuticals) is a pharmaceutical company developing cell-based therapies for the treatment of severe diseases. It provides an IP-protected process for GMP manufacturing of the NK-cell (natural killer cells)-based drug candidate for the treatment of multiple myeloma.